Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
22 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
ICU MEDICAL BELGIUM from Leuven, company number BE0448936388, closed financial year 2025 with a result of € 150,153 after tax. For that financial year ICU MEDICAL BELGIUM recorded a gross margin of € 457,175 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 128,357 to € 150,153. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 17, 2026.
€ 1.4 million
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 150,153
▲ 17% vs 2024
Profit after tax over the fiscal year.
€ 1.1 million
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.3 million.
People and assets in 2025
3
Average over the fiscal year, from the social balance sheet.
€ 326,540
▼ 30% vs 2024
€ 108,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 337,244
▼ 51% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 145,405
▼ 39% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 5,312,224 | - | - | - | |
| Gross margin | - | € 558,236 | € 613,210 | € 457,175 | ▼ 25% |
| Profit after taxes | € 149,505 | € 133,226 | € 128,357 | € 150,153 | ▲ 17% |
| Equity | € 966,870 | € 1,100,095 | € 1,228,453 | € 1,378,605 | ▲ 12% |
| Total debts | € 613,371 | € 498,586 | € 1,034,449 | € 531,968 | ▼ 49% |
| Cash | - | - | - | € 1,050,194 | |
| Retained profit | € 904,870 | € 1,038,095 | € 1,166,453 | € 1,316,605 | ▲ 13% |
| Dividend | € 1,000,000 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 1,580,241 | € 1,598,682 | € 2,262,901 | € 1,910,573 | ▼ 16% |
| Employees (FTE) | 3.5 | 3 | 3 | 3 |
Key figures of ICU MEDICAL BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ICU MEDICAL BELGIUM?
What happened at ICU MEDICAL BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 150,153 (▲ 17% vs 2024). filed late Source: NBB ↗
- Gitte Larsen stepped down as director. NBB
- Louis Philip Jones stepped down as director. NBB
- Gitte Larsen became a director. NBB
- Bonnell Brian became a director. NBB
- Cornelis De Rooij became a director. NBB
- Ramon De Ridder became a director. NBB
- Louis Philip Jones became a director. NBB
In short
From € 149,505 profit in 2022 to € 150,153 profit in 2025.
Paid € 240,369 in corporate taxes since 2022.
Best year ever: 2025, with € 150,153 profit.
On average € 152,400 of value added per employee in 2025.
A new publication or filing at ICU MEDICAL BELGIUM? We notify you, reason included.
Follow ICU MEDICAL BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind ICU MEDICAL BELGIUM are Bonnell Brian, Cornelis De Rooij and Ramon De Ridder. The shares are held by ICU Medical B.V. (100%).
Directors
According to the 2025 annual accounts
Bonnell Brian
Director
since 2022
Cornelis De Rooij
Director
since 2022
Ramon De Ridder
Director
since 2022
Gitte Larsen
Director
since 2022 · until 2025
Louis Philip Jones
Director
since 2021 · until 2025
Shareholders
ICU Medical B.V.
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Martelarenplein 20 box E
3000 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 22 companies are registered at this address.
All companies at this address →CLOOS BENELUX
€ 10,135 gross margin · 2025
VRIENDENKRING TREINPERSONEEL SPOOR LEUVEN
ARCHITECTUURBUREAU VERGAUWEN
€ 88,828 gross margin · 2023
Sonora
€ 190,049 gross margin · 2025
MEPLIS
€ -133,675 gross margin · 2024
+17 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0448.936.388
- VAT number
- BE 0448.936.388
- Registered office
- Martelarenplein 20 bus E, 3000 Leuven
- Names & denominations
- ICU MEDICAL BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 1992
- Peppol
- Active · Active since 29 Jan 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten